Evidence map›Paper›PMID 33672131›Full record

ReviewBioengineering (Basel, Switzerland)2021

Advantages of Additive Manufacturing for Biomedical Applications of Polyhydroxyalkanoates.

Alberto Giubilini, Federica Bondioli, Massimo Messori, Gustav Nyström, Gilberto Siqueira

Abstract readReview
In one paragraph

Review in Bioengineering (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. 3D-Printed Poly(3-hydroxybutyrate-Biomacromolecules · 2023
    Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Biocomposite Inks for 3D Printing.Bioengineering (Basel, Switzerland) · 2021
    Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Alberto GiubiliniDepartment of Engineering and Architecture, University of Parma, 43124 Parma, Italy.ORCID 0000-0002-5253-5248
Federica BondioliDepartment of Applied Science and Technology, Politecnico di Torino, 10129 Torino, Italy.ORCID 0000-0002-4507-3831
Massimo MessoriDepartment of Engineering "Enzo Ferrari", University of Modena and Reggio Emilia, 41125 Modena, Italy.ORCID 0000-0003-3598-4241
Gustav NyströmCellulose & Wood Materials Laboratory, Empa-Swiss Federal Laboratories for Materials Science and Technology, 8600 Dübendorf, Switzerland.
Gilberto SiqueiraCellulose & Wood Materials Laboratory, Empa-Swiss Federal Laboratories for Materials Science and Technology, 8600 Dübendorf, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, biopolymers have been attracting the attention of researchers and specialists from different fields, including biotechnology, material science, engineering, and medicine. The reason is the possibility of combining sustainability with scientific and technological progress. This is an extremely broad research topic, and a distinction has to be made among different classes and types of biopolymers. Polyhydroxyalkanoate (PHA) is a particular family of polyesters, synthetized by microorganisms under unbalanced growth conditions, making them both bio-based and biodegradable polymers with a thermoplastic behavior. Recently, PHAs were used more intensively in biomedical applications because of their tunable mechanical properties, cytocompatibility, adhesion for cells, and controllable biodegradability. Similarly, the 3D-printing technologies show increasing potential in this particular field of application, due to their advantages in tailor-made design, rapid prototyping, and manufacturing of complex structures. In this review, first, the synthesis and the production of PHAs are described, and different production techniques of medical implants are compared. Then, an overview is given on the most recent and relevant medical applications of PHA for drug delivery, vessel stenting, and tissue engineering. A special focus is reserved for the innovations brought by the introduction of additive manufacturing in this field, as compared to the traditional techniques. All of these advances are expected to have important scientific and commercial applications in the near future.

Indexed as

3D printingadditive manufacturingbiomedicinedrug deliverypolyhydroxyalkanoatesscaffoldstissue engineeringvessel stenting

Identifiers

PMID33672131
PMCPMC7926534

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.